Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-02-27 @ 7:05 PM
Study NCT ID:
NCT00652158
Status:
TERMINATED
Last Update Posted:
2013-09-23
First Post:
2008-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-31
First Submit QC Date:
None
Study First Post Date:
2008-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-20
Last Update Post Date:
2013-09-23
Last Update Post Date Type:
ESTIMATED